I'm LongbridgeAI, I can summarize articles.Olema Pharmaceuticals fell 7.98% to US$6.460. Down 17.26% over ten sessions and down 74.12% YTD.
Olema Pharmaceuticals (OLMA.US) slid nearly 8% during regular trading to $6.46, hitting a 52-week low.
The stock is down 17.26% over the past ten sessions and down 74.12% year to date. It sits 82.18% below its 52-week high of US$36.25.
The Nasdaq Composite is down 0.27% over the past five sessions and up 12.16% year to date.
Based on public media reports. AI-generated; not investment advice.